Cargando…

Updates on role of human recombinant activated protein C in patients with sepsis and severe sepsis: Changed scenario after PROWESS SHOCK trial

Detalles Bibliográficos
Autor principal:	Shukla, Aparna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546260/ https://www.ncbi.nlm.nih.gov/pubmed/23325958 http://dx.doi.org/10.4103/0019-5049.104597

Ejemplares similares

Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)
por: Levy, Howard, et al.
Publicado: (2005)

Statistical analysis plan of PROWESS SHOCK study
por: Thompson, B. Taylor, et al.
Publicado: (2010)

Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis
por: Laterre, Pierre-François, et al.
Publicado: (2008)

The outcomes of severe sepsis and septic shock in the UK
por: Reuben, Adam D, et al.
Publicado: (2006)

Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis
por: Shukla, Aparna, et al.
Publicado: (2010)

Meta-analysis assessing the effectiveness of intravenous vitamin C in patients with sepsis and septic shock
por: Tariq, Muhammad Ali, et al.
Publicado: (2022)

Procalcitonin-guided therapy in severe sepsis and septic shock
por: Gu, Wan-Jie, et al.
Publicado: (2014)

Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial
por: Póvoa, Pedro, et al.
Publicado: (2015)

The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
por: Vincent, J, et al.
Publicado: (2004)

Salmonella Infection in Newborn - Varied Presentation from Sepsis to Shock
por: Sharan, Rajiv, et al.
Publicado: (2013)

The role of speckle tracking echocardiography for prognostication in patients with severe sepsis or septic shock
por: Sanfilippo, Filippo, et al.
Publicado: (2016)

Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
por: Koyama, Kansuke, et al.
Publicado: (2017)

The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
por: Beale, R, et al.
Publicado: (2004)

The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update
por: Annane, Djillali
Publicado: (2016)

Life-threatening severe sepsis following stapled hemorrhoidopexy
por: Agarwal, Apurva, et al.
Publicado: (2014)

Severe Sepsis and Septic Shock
por: Opal, Steven M.
Publicado: (2008)

CERN’s prowess in nothingness: Vacuum technology
por: Chiggiato, Paolo
Publicado: (2018)

Ivabradine in sepsis
por: Nair, Abhijit S, et al.
Publicado: (2013)

Sepsis definitions
por: Dias, Fernando Suparregui
Publicado: (2017)

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

The revised recommendation for administering vitamin C in septic patients: The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020
Publicado: (2022)

Letter on Update to the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Protocol
por: Frommelt, Mark A., et al.
Publicado: (2020)

Significance of adrenomedullin and the role of adrecizumab in sepsis
por: Nair, Abhijit
Publicado: (2021)

Application of updated guidelines on diastolic dysfunction in patients with severe sepsis and septic shock
por: Clancy, David J., et al.
Publicado: (2017)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

Odontogenic-related sepsis
por: Wereski, Ryan
Publicado: (2016)

Recommendations for long-term outcomes in sepsis and septic shock: a comparison between Japanese and international guidelines
por: Kawai, Yusuke, et al.
Publicado: (2022)

Facial Attractiveness as a Function of Athletic Prowess
por: Bagozzi, Richard P., et al.
Publicado: (2018)

National estimates of severe sepsis (our experience in Novi Sad, Serbia)
por: Gvozdenović, Ljiljana, et al.
Publicado: (2013)

Mechanism of C5a-induced immunologic derangement in sepsis
por: Xu, Ruonan, et al.
Publicado: (2017)

Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
por: Vincent, J, et al.
Publicado: (2004)

In response: Letter on update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol
por: Lindsell, Christopher J., et al.
Publicado: (2020)

Sepsis: Mr. Machado's criteria
por: Gomes, José Andrade
Publicado: (2017)

The application of anticoagulant therapy to sepsis
por: Thachil, Jecko, et al.
Publicado: (2017)

Antimicrobials administration time in patients with suspected sepsis: faster is better for severe patients
por: Jouffroy, Romain, et al.
Publicado: (2020)

Liability of sepsis is hardly determined by the COXI variant m.6459T>C
por: Finsterer, Josef
Publicado: (2018)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Sepsis Bundle Adherence Is Associated with Improved Survival in Severe Sepsis or Septic Shock
por: Milano, Peter K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ms1foejbg3h44r1n8klv6fmg0m